Teva Pharma (TEVA) Prelim. Q2 Revenue, EPS Outpace Views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. QCOM
6. IRT
7. ASO
8. UNFI
9. SPY
10. EVMN

Go back to Teva Pharma (TEVA) Prelim. Q2 Revenue, EPS Outpace Views
TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 36.98 +0.22 (0.60%)
Previous Close $36.76    52 Week High $66.55 
Open $36.82    52 Week Low $37.82 
Day High $37.32    P/E N/A 
Day Low $36.81    EPS $0.00 
Volume 634,789